Novo Nordisk to take legal action against Hims & Hers for Wegovy compounding
COPENHAGEN, Feb 5 (Reuters) – Novo Nordisk said on Thursday it would take legal action against Hims &…
SA sales of weight-loss drugs surge amid global rise in lawsuits
Sales of weight-loss drugs are sky-rocketing in South Africa, as it has in other parts of the world.…
Eli Lilly Soared by 39% in 2025, but Here’s Another Healthcare Stock to Buy in 2026
Eli Lilly’s (NYSE: LLY) share price jumped 39% in 2025, driven by investors eager to benefit from the…
Novo’s Wegovy pill tracks over 26,000 prescriptions
Jan 30 (Reuters) – Novo Nordisk’s Wegovy pill hits over 26,000 U.S. prescriptions in the second full week…
US FDA Approves First Daily Oral GLP‑1 Treatment for Weight Management, Showing Comparable Results to Injectable Therapy
The US Food and Drug Administration (FDA) has approved Novo Nordisk’s new once-daily pill for weight management, designed…
Roche Shares Rise After Obesity Drug Shows 18% Greater Weight Loss
This article first appeared on GuruFocus. Roche Holding AG (RHHBY) is beginning to show tangible progress in obesity…
How Will Ozempic and Wegovy Sales Aid NVO’s Upcoming Q4 Results?
Novo Nordisk NVO is a dominant player in the cardiometabolic space, mainly due to the encouraging uptake of its…
This Healthcare Stock Could Soar by 40% in 2026
Novo Nordisk had a rough stretch in 2025 that eventually led to it “firing” its CEO. The new…
Ozempic Brings Back the ‘Mac vs PC’ Ads for the GLP-1 Era
Novo Nordisk’s Ozempic kicked off the GLP-1 craze when it launched in 2018 for the treatment of Type…
How Will Mounjaro and Zepbound Sales Aid LLY’s Upcoming Q4 Results?
Eli Lilly LLY has emerged as a dominant force in the cardiometabolic market, driven by strong demand for its…
Weight loss drug Wegovy to be listed on PBS
Wegovy will be heavily subsidised for Australians with severe obesity, who have also experienced a cardiovascular event, like…
Health Canada approves 1st GLP-1 daily pill. Here’s who can take it – National
Health Canada has approved a GLP-1 pill for the first time. The once-a-day semaglutide pill is approved for…